The Priority Review

Tag

BXCL501

1 story

  1. Clinical trials

    Results posted for dexmedetomidine study in dementia agitation

    Results for this study were first posted on ClinicalTrials.gov on October 1, 2026. The study, a Phase 3, randomized, double-blind, placebo-controlled trial, enrolled 13 participants and was terminated.